证 券 研 究 报 告 行业周报 调整带来买入良机，聚焦核心阿尔法 新能源汽车行业周报 投资评级： （ ） 报告日期： 推荐 维持 2025年04月20日 ◼ 分析师：黎江涛 ◼ SAC编号：S1050521120002 投 资 要 点 继续看好板块机会。根据中汽协数据，2025年3月，新能源汽车产销分别完成127.7万辆和123.7万辆，环比分别增长43.9% 和38.7%，同比分别增长47.9%和40.1%。1-3月，新能源汽车产销累计完成318.2万辆和307.5万辆，同比分别增长50.4%和 47.1%，新能源汽车新车销量达到汽车新车总销量的41.2%。供给端，电池及主机厂新品不断推出，需求端反馈积极，政策也 不断发力。价格层面，产业链历经价格大幅下行，资本开支不断收缩，供需格局不断优化，行业协会、产业链公司均在积极优 化产能与供给，力争价格保障企业盈利。整体而言，产业链价格处于底部，价格易涨难跌，需求端韧性强劲，调整带来布局良 机，产业链核心公司估值处于历史低水平，看好产业链优质公司。 政策持续呵护，供给端部分企业开始收缩资本开支，供需结构在边际优化，2025年产业链价格触底修复。继续优选有望贡献 ...

2025 年 04 月 19 日 业绩短期承压，期待下游改善 买入(维持) 事件 | 分析师：孙山山 | S1050521110005 | | --- | --- | | sunss@cfsc.com.cn | | | 联系人：肖燕南 | S1050123060024 | | xiaoyn@cfsc.com.cn | | | 基本数据 | 2025-04-18 | | --- | --- | | 当前股价（元） | 31.4 | | 总市值（亿元） | 39 | | 总股本（百万股） | 124 | | 流通股本（百万股） | 115 | | 52 周价格范围（元） | 14.97-37 | | 日均成交额（百万元） | 173.67 | 市场表现 -40 -20 0 20 40 60 80 100 120 (%) 熊猫乳品 沪深300 资料来源：Wind，华鑫证券研究 相关研究 1、《熊猫乳品（300898）：盈利能 力改善，炼乳增长势能延续》2024- 08-19 2、《熊猫乳品（300898）：利润端 增速亮眼，多极增长逻辑清晰》 2024-04-25 3、《熊猫乳品（300898）：新品渠 道布局顺利 ...

内需看 A 计划 科技与消费并驾齐驱 推荐(维持) 投资要点 | 分析师：朱珠 | S1050521110001 | | --- | --- | | zhuzhu@cfsc.com.cn | | | 分析师：于越 | S1050522080001 | | yvyue@cfsc.com.cn | | 行业相对表现 2025 年 04 月 20 日 | 表现 | 1M | 3M | 12M | | --- | --- | --- | --- | | 传媒(申万) | -11.8 | 1.9 | 12.1 | | 沪深 300 | -5.9 | -1.0 | 5.7 | 市场表现 -30 -20 -10 0 10 20 30 40 (%) 传媒 沪深300 资料来源：Wind，华鑫证券研究 相关研究 1、《传媒行业周报：持续看好内需 且洼地的成长型选手》2025-04-12 2、《传媒行业专题报告："情绪经 济"专题》2025-04-10 3、《传媒行业周报：看内需寻成长 型选手》2025-04-05 ▌ 本周观点更新 在外部不确定性下，国家政策护航作用逐步显现，A 股相对 获政策传导较快，进而我们看好内需下的 A ...

2025 年 04 月 20 日 内需看 A 计划 科技与消费并驾齐驱 ▌ 本周观点更新 推荐(维持) 投资要点 | 分析师：朱珠 | S1050521110001 | | --- | --- | | zhuzhu@cfsc.com.cn | | | 分析师：于越 | S1050522080001 | | yvyue@cfsc.com.cn | | 行业相对表现 | 表现 | 1M | 3M | 12M | | --- | --- | --- | --- | | 传媒(申万) | -11.8 | 1.9 | 12.1 | | 沪深 300 | -5.9 | -1.0 | 5.7 | 市场表现 -30 -20 -10 0 10 20 30 40 (%) 传媒 沪深300 资料来源：Wind，华鑫证券研究 相关研究 1、《传媒行业周报：持续看好内需 且洼地的成长型选手》2025-04-12 2、《传媒行业专题报告："情绪经 济"专题》2025-04-10 3、《传媒行业周报：看内需寻成长 型选手》2025-04-05 在外部不确定性下，国家政策护航作用逐步显现，A 股相对 获政策传导较快，进而我们看好内需下的 A ...

Investment Rating - The report maintains a "Buy" investment rating for the company [2][9] Core Views - The company has achieved steady revenue growth driven by both organic and external factors, with a 14.40% year-on-year increase in revenue to 1.567 billion yuan and a 13.21% increase in net profit to 392 million yuan for 2024 [4][9] - The company demonstrates operational resilience through effective cost control and a high dividend policy, proposing a cash dividend of 5 yuan per 10 shares for 2024 [4] - Strategic breakthroughs have been made through mergers and acquisitions, with significant contributions from acquired companies and a 50% increase in overseas revenue, reaching 200 million yuan [5][9] - The company is focusing on technological advancements and capacity expansion, with a research investment of 75.77 million yuan in 2024 and the successful production of diamond-coated seals [8][9] Summary by Sections Financial Performance - In 2024, the company reported revenue of 1.567 billion yuan, a 14.40% increase year-on-year, and a net profit of 392 million yuan, reflecting a 13.21% growth [4][11] - The gross profit margin decreased by 1.31 percentage points to 48.34%, while the expense ratio improved by 1.49 percentage points to 20.24% [4] Mergers and Acquisitions - The company has successfully integrated several acquisitions, including Yutai Technology and Xin Di Pei Er, with net profits of 29.90 million yuan and 28.18 million yuan respectively, showing significant synergy effects [5] - The acquisition of KS GmbH further strengthens the company's upstream integration capabilities in the rubber and plastic sealing sector [5] International Expansion - The company has seen a notable increase in international business, with overseas revenue growing by 50% to 200 million yuan, successfully entering high-end projects in Abu Dhabi and Algeria [5] Technological Development - The company invested 75.77 million yuan in R&D, achieving breakthroughs in core technologies and securing 19 patents in 2024 [8] - Capacity upgrades are ongoing, with the production line for rubber and plastic seals fully operational and efficiency improvements through PLM/WMS systems [8] Profit Forecast - Revenue forecasts for 2025, 2026, and 2027 are 1.761 billion yuan, 2.015 billion yuan, and 2.239 billion yuan respectively, with corresponding EPS of 2.16 yuan, 2.50 yuan, and 2.74 yuan [9][11]

业绩增长符合预期，内生外延双轮驱动成长 —中密控股（300470.SZ）公司事件点评报告 买入(维持) 事件 分析师：尤少炜 S1050525030002 yousw@cfsc.com.cn | 基本数据 | 2025-04-18 | | --- | --- | | 当前股价（元） | 34.93 | | 总市值（亿元） | 73 | | 总股本（百万股） | 208 | | 流通股本（百万股） | 197 | | 52 周价格范围（元） | 28.81-41.8 | | 日均成交额（百万元） | 106.0 | 市场表现 2025 年 04 月 19 日 相关研究 1、《中密控股（300470）：业绩稳 步增长，股权激励彰显信心》2024- 04-27 中密控股 4 月 14 日发布 2024 年年度报告:2024 年实现营业 收入 15.67 亿元（同比增加 14.40%），归母净利润 3.92 亿 元 (同比增加 13.21%)，扣非归母净利润 3.66 亿元(同比增 加 16.45%)。 投资要点 ▌业绩稳健增长，费用管控与分红彰显经营韧性 2024 年中密控股实现营收 15.67 亿元，同比增长 1 ...

Investment Rating - The report maintains a "Buy" investment rating for the company [1] Core Views - The company's performance is under short-term pressure, but there are expectations for the effectiveness of reforms [1] - The overall industry is in an adjustment phase, with a positive outlook on supply chain platform construction [6] - E-commerce is experiencing rapid growth, and channel reforms are anticipated to yield results [7] Summary by Sections Financial Performance - In 2024, total revenue and net profit attributable to the parent company were 9.464 billion and 0.44 billion yuan, respectively, reflecting a year-on-year decline of 6% and 81% [5] - The fourth quarter of 2024 saw total revenue and net profit of 1.633 billion and -0.123 billion yuan, with total revenue down 13% year-on-year [5] - The gross margin and net margin for 2024 were 9% and 0.5%, down 1.7 and 1.9 percentage points year-on-year [5] - Operating cash flow improved, with a 54% year-on-year increase in operating net cash flow to 4.36 billion yuan [5] Industry Overview - The wine industry, including both white and red wine, is experiencing revenue declines, with white wine revenue at 8.76 billion yuan and red wine at 420 million yuan, down 6.77% and 13.68% year-on-year, respectively [6] - The company is deepening cooperation with Penfolds and has obtained exclusive agency rights for several red wine products, expanding its product range [6] E-commerce and Channel Strategy - E-commerce revenue for 2024 reached 2.092 billion yuan, with significant growth driven by marketing strategies during the Spring Festival [7] - The company is focusing on three channel models: Huazhi Wine 3.0, Huazhi Famous Wine Library, and Huazhi Preferred, to adapt to market changes and enhance brand presence [8] Earnings Forecast - The company is expected to have EPS of 0.26, 0.42, and 0.60 yuan for 2025, 2026, and 2027, respectively, with corresponding PE ratios of 61, 37, and 26 times [9]

Investment Rating - The report assigns a "Buy" rating for Chuanheng Co., Ltd. (002895.SZ) for the first time [1][10]. Core Views - The significant increase in phosphoric acid production and sales has driven the company's high growth in performance, with a total revenue of 5.906 billion yuan in 2024, up 36.72% year-on-year, and a net profit attributable to shareholders of 956 million yuan, up 24.80% year-on-year [1][2]. Summary by Sections Revenue Growth - The company's revenue increased by 1.586 billion yuan year-on-year, primarily due to the production launch of the 200,000 tons/year semi-hydrated and dihydrate phosphoric acid and deep processing project by its subsidiary, Guangxi Pengyue. This new capacity significantly boosted product sales [2]. - Phosphoric acid production and sales grew by 96.57% and 107.89% year-on-year, contributing 1.872 billion yuan to revenue, a year-on-year increase of 120.63% [2]. - Feed-grade dicalcium phosphate production and sales increased by 23.11% and 15.81%, contributing 1.445 billion yuan to revenue, a year-on-year growth of 20.16% [2]. - Monoammonium phosphate production and sales rose by 23.57% and 15.68%, contributing 1.176 billion yuan to revenue, a year-on-year increase of 26.21% [2]. Cost and Cash Flow - The overall expense ratio decreased, with sales, management, and financial expense ratios down by 0.11%, 1.42%, and 1.36% respectively, while R&D expenses increased slightly [3]. - The net cash flow from operating activities for 2024 was 859 million yuan, an increase of 331 million yuan year-on-year, mainly due to increased sales profits and government subsidies [3]. Shareholder Returns and R&D Investment - The company maintained a stable dividend policy, distributing 12.00 yuan (including tax) per 10 shares, with a payout ratio of 67.58% and a dividend yield of 4.88% [4]. - R&D expenses increased by 37.37% year-on-year, focusing on projects such as the stability research of semi-hydrated phosphogypsum filling bodies and new crystallization processes [4]. Profit Forecast - The company is expected to gradually expand its phosphate rock production capacity, with projected net profits attributable to shareholders of 1.217 billion yuan, 1.407 billion yuan, and 1.688 billion yuan for 2025, 2026, and 2027 respectively, corresponding to PE ratios of 10.2, 8.8, and 7.3 times [10][12].

2025 年 04 月 18 日 技术筑基绿色智造，全链协同驱动全球增长 —浙江龙盛（600352.SH）公司事件点评报告 浙江龙盛发布 2024 年年度报告：2024 年，公司实现总营业 收入 158.84 亿元，同比增长 3.80%；实现归母净利润 20.30 亿元，同比增长 32.36%。其中，2024Q4 单季度实现营业收入 52.74 亿元，同比增长 17.90%，环比增长 44.29%；实现归母 净利润 6.77 亿元，同比增长 6.63%，环比增长 50.03%。 投资要点 ▌逆势增长显韧性，多元布局拓空间 公司通过搭建覆盖产品开发、工艺创新、色彩应用服务及可 持续解决方案的全球研发体系，构筑核心技术壁垒。凭借近 1900 项境内外专利储备，形成对产品矩阵的强效技术支撑。 在国内染料、助剂行业面临产能过剩、同业竞争加剧导致平 均利润率承压的背景下，公司实现染料业务全球销售量同比 增长 7.17%，染料/助剂营业收入分别同比增长 0.94%和 7.63%，显著优于行业水平；中间体业务在平稳市场环境下实 现量价齐升，销售量同比增长 16.55%，营收增长 4.58%，体 现产业链延伸优势；房地产业务 ...

Investment Rating - The report assigns a "Buy" rating for Chuanheng Co., Ltd. (002895.SZ) for the first time [1][10]. Core Views - The significant increase in phosphoric acid production and sales has driven the company's high growth in performance, with a total revenue of 5.906 billion yuan in 2024, up 36.72% year-on-year, and a net profit attributable to shareholders of 956 million yuan, up 24.80% year-on-year [1][2]. Summary by Sections Revenue Growth - The company's revenue increased by 1.586 billion yuan year-on-year, primarily due to the production launch of the 200,000 tons/year semi-hydrated and dihydrate phosphoric acid and deep processing project by its subsidiary, Guangxi Pengyue. This new capacity significantly boosted product sales [2]. - Phosphoric acid production and sales grew by 96.57% and 107.89% year-on-year, contributing 1.872 billion yuan to revenue, a year-on-year increase of 120.63% [2]. - Feed-grade dicalcium phosphate production and sales increased by 23.11% and 15.81%, contributing 1.445 billion yuan to revenue, a year-on-year growth of 20.16% [2]. - Monoammonium phosphate production and sales rose by 23.57% and 15.68%, contributing 1.176 billion yuan to revenue, a year-on-year increase of 26.21% [2]. Cost and Cash Flow - The overall expense ratio decreased, with sales, management, and financial expense ratios down by 0.11%, 1.42%, and 1.36% respectively, while R&D expenses remained stable [3]. - The net cash flow from operating activities for 2024 was 859 million yuan, an increase of 331 million yuan year-on-year, mainly due to increased sales profits and government subsidies [3]. Shareholder Returns and R&D Investment - The company maintained a stable dividend policy, distributing 12.00 yuan (including tax) per 10 shares, with a payout ratio of 67.58% and a dividend yield of 4.88% [4]. - R&D expenses increased by 37.37% year-on-year, focusing on projects such as the stability research of semi-hydrated phosphogypsum filling bodies and new crystallization processes [4]. Profit Forecast - The company is expected to gradually expand its phosphate rock production capacity, with projected net profits attributable to shareholders of 1.217 billion yuan, 1.407 billion yuan, and 1.688 billion yuan for 2025-2027, corresponding to PE ratios of 10.2, 8.8, and 7.3 times respectively [10][12].